Powered by Business Wire

CEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target Population

(Graphic: Business Wire)
(Graphic: Business Wire)

Download